Alysia BirkholzCEO Texcell-North America at TexcellSpeaker
Dr. Alysia Birkholz is the CEO of Texcell's North American division, a prominent contract testing organization specializing in safety testing for adventitious agents in the biopharmaceutical and medical device sectors. In her role, she directs the site, formulates scientific and operational strategies, and collaborates with the global leadership team to advance the mission of safeguarding the future of medicines. Holding a PhD in Biological Sciences from UC San Diego and a BA in Biochemistry and Biology from St. Mary's College of Maryland, Dr. Birkholz brings a strong academic background to her leadership. She has undergone project management training at the Isenberg School of Management, UMass Amherst, and received additional training at the National Institutes of Health (NIH). Dr. Birkholz's diverse career spans roles in career development, professional training, and she is a sought-after guest speaker. Beyond her executive responsibilities, she contributes as a board member for life science education programs and actively mentors biotech startups, showcasing her commitment to advancing the industry and nurturing emerging talent.